chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received vaccine at 6:20pm on 8/6/18. Patient consent form indicated patient had not previously had a reaction to a vaccine. She waited near pharmacy area for 15-20 minutes and came by to let us know she was doing fine before she left. She called on 8/8/18 to inform us that shortly after she left the pharmacy (unknown duration of time), the left side of her face and her left arm started to swell to the point that she had to go to the Emergency Room. They gave her BENADRYL and she continued to take BENADRYL over the counter. She stated that she is doing fine, but the swelling is not going down very quickly. Tried to contact the patient later in the day to check on her, but her phone went straight to voicemail.
RAN FEVER, HAD CHILLS AND BODY ACHES  FROM EVENING ON SAME DAY OF DOSE FOR ABOUT 2 DAYS
Pt was given varicella vax at 7:30 am. Reported back to employee Heath at 1355 with rash- Rash was located bilaterally on arms, below elbow. No SOB, problems swallowing large whelps. No other area BENADRYL 50mg po given.
An estimation of about five minutes after receiving the Covid19 (Moderna) vaccine, my heartrate increased to around 100 beats a minute (as told to me by Dr. ). My breathing felt a little different but it could have been from wearing two masks for a longer period of time than usual. After ten or fifteen minutes, I felt sort of dizzness and it didn't feel quite normal around my eyes and forehead. The staff were extremely attentive to me. I probably was there after the shot for 30-45 minutes. Dr.  suggested my symptoms was due to anxiety and out of an abundance of caution, the emergency squad was called and I was taken to  Hospital Emergency Department.
Temperature excursion that was intermittent; This spontaneous report was received from a registered nurse, concerning a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions and concomitant medications were not reported.   Since 27-JUL-2020, varicella virus vaccine live (oka/merck)(VARIVAX) were improperly stored and had temperature excursions.   On 24-AUG-2020, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 ml for prophylaxis, lot #T002843 (also reported as TOO2843) and expiration date reported as 23-JAN-2022 ).   The temperature excursion was reported from -14°C to -10°C (max -9.5°C), during a time frame of 38 hours and 30 minutes. There was previous temperature excursion.   A digital data logger was involved.; Sender's Comments:  US-009507513-2008USA014701: US-009507513-2008USA014711:
dizziness post vaccine, placed in wheelchair and taken to med area. Laid down and given snacks and water.
Didn?t have any symptoms barely had soreness after injection on 2/10 around 7:00 on 2/19 my arm was itching and hot to the touch my daughter told me it?s swollen took Benadryl that night woke up the next day still itching and hot but arm is a little tight googled it and found out it?s a side effect took ibuprofen and Benadryl.
Pfizer-BioNTech COVID-19 Vaccine EUA  Weakness in legs, and headache stated about six hours ago, and continuing.
Writer received call on 3/8/21 from patient stating that the evening she received her vaccine (3/4/21), she began experiencing a headache and a red, pruritic rash on her abdomen ("looks like roseola"). By the next day the rash had become "full blown" on her abdomen and wrapped around to her back. Unrelieved by any home remedy. Denies SOB, N, V, or other associated symptoms. Rash had not improved at time of call. Writer advised she be evaluated by her PCP for possible treatment of rash and to determine whether she should receive 2nd vaccine in series. Phone call to patient on 3/9/21 to check status. She reports she saw PCP who gave injection of steroid and a steroid taper. He recommends against receiving 2nd vaccine d/t high suspicion of adverse reaction to the vaccine. At time of call, patient is in NAD and notes some improvement in rash.
This spontaneous report was received from a pharmacist and refers to a patient of unknown demographics. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 23-JUL-1998, the patient was vaccinated with the first dose of RECOMBIVAX HB injection (dose, lot number and expiration date were not reported). The patient subsequently received the second dose of RECOMBIVAX HB on 25-AUG-1998. On 10-AUG-2017, the patient visited the reporting pharmacist's office to receive the third dose of RECOMBIVAX HB. There were no adverse symptoms reported. It was not reported if the patient received the third dose of the vaccine. Additional information has been requested.
On April 23, 2021, we flew from one location to another for a  visit.   Patient became dizzy with vertigo and nausea, which worsened as the day progressed.   We had to visit the ER that evening.  His heart rate was @ 103 bpm and the ER evaluated him for several hours. The ER prescribed Meclizine.   When we returned home patient saw a vestibular specialist @ Hospital and was diagnosed with vestibular neuronitis.
Patient tested positive for Covid at Hospital on 9/07/2021. Has received Pfizer vaccine with 1st dose on 02/22/2021 and 2nd dose on 03/15/2021 per ED Note: Patient is a 76-year-old female with past medical history of benign essential hypertension, diverticulosis and dyslipidemia presenting to emergency department with chief complaint of hypotension and shortness of breath.  Patient states that she tested positive for COVID-19 viral illness on Tuesday of last week.  She states that since that time she has been experiencing mild shortness of breath.  She also states that yesterday she had a temperature of 102 Fahrenheit and oxygen saturation of 90% on room air.  This morning she states that she is feeling some dizziness in addition to her shortness of breath, headache and also states that her heart "feels like it is beating hard."  She is also describing some nausea and a cough beginning yesterday which is productive of "white sputum."  Patient denies vomiting, loss of taste or smell, chest pain, abdominal pain, numbness, weakness or tingling her extremities.
2nd shot administered more than 36 days later; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd shot administered more than 36 days later) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd shot administered more than 36 days later). On 11-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd shot administered more than 36 days later) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.
Case received on 07 October 2011 from a healthcare professional. A male patient, with no medical history reported, had received on an unspecified date his dose of FLUZONE HD (batch number UH444AB, number in series, route and site of administration not reported). No concomitant therapy was reported. On an unspecified date after immunization, the patient developed chills and red eyes. No corrective treatment was reported. The final outcome was not reported. Documents held by sender: none.
Lost sense of taste and smell; Lost sense of taste and smell; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Lost sense of taste and smell) and ANOSMIA (Lost sense of taste and smell) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced AGEUSIA (Lost sense of taste and smell) and ANOSMIA (Lost sense of taste and smell). At the time of the report, AGEUSIA (Lost sense of taste and smell) and ANOSMIA (Lost sense of taste and smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Pt with new onset nausea, vomiting, acid reflux symptoms starting within days of COVID vaccination, continuing to this day
Dizziness, Heart Racing, Panic attacks, High anxiety Breathing Problems, Vertigo (4 weeks)
severe itching; burning with hives; dermatographia; Hives, the hives appeared and disappeared periodically; Nausea; vomiting; severe body aches; severe fatigue; I had a sore arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (I had a sore arm), PRURITUS (severe itching), BURNING SENSATION (burning with hives), MECHANICAL URTICARIA (dermatographia) and URTICARIA (Hives, the hives appeared and disappeared periodically) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 066F21A, 012M20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced PAIN IN EXTREMITY (I had a sore arm). On 06-Nov-2021, the patient experienced NAUSEA (Nausea), VOMITING (vomiting), MYALGIA (severe body aches) and FATIGUE (severe fatigue). On 15-Nov-2021, the patient experienced PRURITUS (severe itching), BURNING SENSATION (burning with hives), MECHANICAL URTICARIA (dermatographia) and URTICARIA (Hives, the hives appeared and disappeared periodically). At the time of the report, PAIN IN EXTREMITY (I had a sore arm), PRURITUS (severe itching), BURNING SENSATION (burning with hives), MECHANICAL URTICARIA (dermatographia), URTICARIA (Hives, the hives appeared and disappeared periodically), NAUSEA (Nausea), VOMITING (vomiting), MYALGIA (severe body aches) and FATIGUE (severe fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided.   This case was linked to MOD-2021-435165, MOD-2021-435187 (Patient Link).
Nose bleeds every morning when wake up from sleeping. No treatment. The symptoms stopped after 5 days
Pt admitted 3/22/21 with several week history of Chest congestion, cough, fever, shortness of breath. Had COVID vaccine just before started having symptoms.  Decline in respiratory status requiring high flow O2 delivery and admission to ICU for monitoring.
Got shot Thurs. 4/8/21 and  had daily weird side effects until 4-16-21 when I Woke up with severe headache,  after several days of pain that traveled from big toe up leg over buttocks where a rash broke out on my   back right hip at bikini line area. It was painful, itchy and  some blisters appeared the following day. I went to a walk in clinic and was diagnosed with shingles and given medicine for 7 days. I completed the medicine and blisters have dried up.
Reflux like heartburn and a metallic taste sensation which lingers for hours; Reflux like heartburn and a metallic taste sensation which lingers for hours; This spontaneous case was reported by a patient and describes the occurrence of DYSPEPSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours) and DYSGEUSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Unknown drug.).    On 02-Feb-2022 at 4:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2022, the patient experienced DYSPEPSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours) and DYSGEUSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours). On 19-May-2022, DYSPEPSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours) and DYSGEUSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours) had resolved.            No concomitant medications were reported. The patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. Co-suspect product included non-company product, unspecified Pfizer medication for treatment of COVID-19. The patient received an unspecified Pfizer medication (unknown route) from 15-May-2022 to 19-May-2022.   No treatment information was reported. Device Date was reported as 19May2022.
Severe shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Severe shoulder pain) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced ARTHRALGIA (Severe shoulder pain). The patient was treated with PARACETAMOL (TYLENOL) for Shoulder pain, at an unspecified dose and frequency and IBUPROFEN for Shoulder pain, at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (Severe shoulder pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products were reported.
No additional AE/PQC reported; a temperature excursion for VARlVAX, vaccine  have been administered; This spontaneous report has been received from a registered nurse (also reported as medical assistant) referring to a 4 years old patient. Information about concurrent condition, concomitant medication and medical history was not provided.  On 14-SEP-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (dose: 1(unit not provided), lot#: U010400 with expire date 01-APR-2023; strength and route were not reported) for prophylaxis (product storage error). The vaccine experienced an excursion of -10 degree Celsius to 8 degree Celsius (4C) for 20 minutes on 07-SEP-2021 during transport and -10 degree Celsius to 8 degree Celsius (4C) for 20 minutes on 09-SEP-2021 during transport. Previous temperature excursion was -10 degree Celsius to 8 degree Celsius for 7 hours and 30 minutes. No adverse events reported.   This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2109USA005628:
States started having hives the next day on 10/6/10 in AM only to rt arm at area of injection, smaller hive 2cm proximal to injection site, rt dorsal wrist hive. Itching. She put an ice pac to site and has pain of 4-6/10.  Then she went to see Provider on 10/7/10 at same clinic she received her flu injection.
Symptoms started approximately 20 minutes after inaction was given. Patient first reported  blurred vision, tongue and lip tingling and numbness. Patient expressed feeling short of breath, but not observed. SPO@ was at 100%, RR 12-16. She then reported her throat was tight. She was conversational and able to drink water. She was given Benadryl 50 mg and taken by ambulance to the ER incase reaction continued to worsen.
Information has been received from a Nurse Practitioner concerning a 12 year old female who on 30-JUL-2007, was vaccinated with her first dose of GARDASIL. On 27-SEP-2007, she was vaccinated with her second dose of GARDASIL. On 27-DEC-2007, she was vaccinated with her third dose of GARDASIL. At a recent wellness visit, the patient told the nurse practitioner, that she had had some hair loss on her scalp, following each dose. Additional information has been requested.
Information has been received from a registered nurse concerning a child (age and gender unknown), who, on an unspecified date, was vaccinated with a dose of of Hib conj vaccine (OMPC). Subsequently, the patient experienced diarrhea, vomiting, and a low grade fever. The physician was contacted by phone. at the time of the report, the outcome of the patient was unknown. No product quality complaint was involved. This is one of two reports from the same source. Additional information has been requested.
Pt received the vaccine in l-deltoid area and within seconds lost consciousness. After being unconscious for roughly ten seconds, pt was arousable by calling his name and lightly shaking him. Pt was seated during his loss of consciousness, was caught by the nurse administering the shot, pt did not hit his head or suffer any trauma. Pt was assisted to a stretcher, given water to drink and his vital signs were monitored. Upon initial assessment, pt was A&O x 4, GCS 15, blood pressure 88/60, pulse 58, pupils equal and reactive to light, lung sounds clear, respirations 16 and non-labored. Pt denied ever fainting before, denied any allergies, medical history, denied taking prescription or over the counter medications, and denied birth defects. Pt was reassessed after about 5 minutes of initial assessment. A&Ox4, GCS 15, BP102/68, PR 78, PEARL, LS clear, RR 16 non-labored. Pt was continuously monitored for 30 minutes and advised to follow up with his primary doctor for an assessment of new-onset syncopal episode.  PT's mood improved and was reassessed for vitals before leaving the clnic. A&0x4  GCS 15, BP 118/80, PR 84, PEARL, LS clear, RR 16-non-labored, PT released from care and exited the site with no further findings.
The vaccine was administered at approx. 14:15 on 4/5/22. Towards the end of the 15min monitoring period, I experienced flushing of the skin, coughing, sweating, and itchiness across my body. My neck was particularly pink and itchy. At this time RPN gave me a glass of water since I became nauseous. After being suggested to take my blood pressure, the automatic blood pressure machine reported my blood pressure to be high (128/82) at 14:43 (I donate blood and do not have any phobia of needles nor did I experience anxiousness when receiving the vaccine). Soon after the test, I began to perspire and experience chills despite being flushed. It was at this time that I began to feel extremely tired and lightheaded. After being requested to stay at the facility RPN gave me "20mL (50mg) of Benadryl in case of allergic reaction". During this time she suggested that I consider going to my primary clinic, the ER, or an urgent care sight. 15min later she offered to call an ambulance, which I declined, and cautiously allowed me to go home at 15:21. Once home (approx. 15min later) I collapsed onto the couch to take a nap before my 16:00 class. At this time I do not have a fever but all symptoms remain with the addition of bodily aches. Soon after the test, I began to perspire and experience chills despite being flushed. It was at this time that I began to feel extremely tired and lightheaded.
No further AE/PQC Reported; The patient was administered an improperly stored dose of GARDASIL 9; This spontaneous report was received from a nurse and was referring to patient of unknown gender and age. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies, nor concomitants medications were not reported.  On 04-SEP-2020, the patient was vaccinated for prophylaxis with improperly stored doses of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9), 0.5 ml Intramuscularly (Dosage regimen and anatomical location were not reported, lot number: S062371 and expiration date: unknown).  The improperly stored of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) experienced a temperature of 48.2 F with time frame of 121 hours, with a previous temperature excursion of 47 F for 31 hours and 45 minutes; 35 F for 2 hours 5 minutes and was call because a digital data logger. No additional adverse event details available.
Evening after injection I became very tired and had to go to bed 2-3 hrs before regular bedtime. The next day I began having flu symptoms (bad headache, body aches, dizziness, fatigue). By noon of that day I had a 101.5 fever that lasted till that evening. Today, Monday 10-8, I still have bad body aches, headache and fatigue.
injection arm swelling; injection arm itching; injection arm red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (injection arm itching), INJECTION SITE ERYTHEMA (injection arm red) and INJECTION SITE SWELLING (injection arm swelling) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced INJECTION SITE PRURITUS (injection arm itching) and INJECTION SITE ERYTHEMA (injection arm red). On 21-Feb-2021, the patient experienced INJECTION SITE SWELLING (injection arm swelling). At the time of the report, INJECTION SITE PRURITUS (injection arm itching), INJECTION SITE ERYTHEMA (injection arm red) and INJECTION SITE SWELLING (injection arm swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Joint pain in left shoulder (same side received shot) 7 days after receiving shot Rash around injection site Hydrocortisone applied  Joint pain gone by 4/1/21 but rash still present and itchy
Redness, swelling at injection site, nausea, achiness, low energy level, can't sleep.
pt recv vax 12AUG96 & 12SEP96 2hr p/dose 2 pt exp urticaria & swollen lips & ears;
This is a 43y.o. male with a history of congenital adrenal hyperplasia, diabetes type 1, history of substance abuse, left frontal inferior mass (s/p craniotomy), seizure disorder, mood disorder and urinary retention who presents to BFH-ED with a chief complaint of possible syncopal episode. Patient states that he does not recall the episode, but often gets lightheaded when he is hypotensive or hypoglycemic. Per chart review, patient was at a care facility and had a possible syncopal episode after getting up to go to the bathroom. Patient admits to lightheadedness, headaches, chills, vomiting and loose stools for the past week He received his COVID booster vaccine 4 days ago. Denies cough, chest pain, shortness of breath, fevers, abdominal pain, lower extremity edema. Patient has a history of meth and cocaine use and reports that he last used them >1 year ago. He also states that he stopped drinking alcohol 2 years ago and tobacco use 8 months ago. Patient had an ankle fracture 2 months ago and is currently wearing a cast, which was changed 12/23/21.
Participant reports waking up four to five days later feeling extremely fatigued and gets shortness of breath regularly, Legs feel heavy. Saw primary care who referred him to the ER. Has since seen a cardiologist and pulmonologist.